Literature DB >> 23439638

OXA-235, a novel class D β-lactamase involved in resistance to carbapenems in Acinetobacter baumannii.

Paul G Higgins1, Francisco J Pérez-Llarena, Esther Zander, Ana Fernández, Germán Bou, Harald Seifert.   

Abstract

We investigated the mechanism of carbapenem resistance in 10 Acinetobacter baumannii strains isolated from the United States and Mexico between 2005 and 2009. The detection of known metallo-β-lactamase or carbapenem-hydrolyzing oxacillinase (OXA) genes by PCR was negative. The presence of plasmid-encoded carbapenem resistance genes was investigated by transformation of A. baumannii ATCC 17978. Shotgun cloning experiments and sequencing were performed, followed by the expression of a novel β-lactamase in A. baumannii. Three novel OXA enzymes were identified, OXA-235 in 8 isolates and the amino acid variants OXA-236 (Glu173-Val) and OXA-237 (Asp208-Gly) in 1 isolate each. The deduced amino acid sequences shared 85% identity with OXA-134, 54% to 57% identities with the acquired OXA-23, OXA-24, OXA-58, and OXA-143, and 56% identity with the intrinsic OXA-51 and, thus, represent a novel subclass of OXA. The expression of OXA-235 in A. baumannii led to reduced carbapenem susceptibility, while cephalosporin MICs were unaffected. Genetic analysis revealed that blaOXA-235, blaOXA-236, and blaOXA-237 were bracketed between two ISAba1 insertion sequences. In addition, the presence of these acquired β-lactamase genes might result from a transposition-mediated mechanism. This highlights the propensity of A. baumannii to acquire multiple carbapenem resistance determinants.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23439638      PMCID: PMC3632948          DOI: 10.1128/AAC.02413-12

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  35 in total

1.  The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii.

Authors:  Jane F Turton; M Elaina Ward; Neil Woodford; Mary E Kaufmann; Rachel Pike; David M Livermore; Tyrone L Pitt
Journal:  FEMS Microbiol Lett       Date:  2006-05       Impact factor: 2.742

2.  Multiplex PCR for rapid detection of genes encoding acquired metallo-beta-lactamases.

Authors:  Matthew J Ellington; James Kistler; David M Livermore; Neil Woodford
Journal:  J Antimicrob Chemother       Date:  2006-12-21       Impact factor: 5.790

3.  Crystal structure of the carbapenemase OXA-24 reveals insights into the mechanism of carbapenem hydrolysis.

Authors:  Elena Santillana; Alejandro Beceiro; Germán Bou; Antonio Romero
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-20       Impact factor: 11.205

4.  Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp.

Authors:  Neil Woodford; Matthew J Ellington; Juliana M Coelho; Jane F Turton; M Elaina Ward; Susan Brown; Sebastian G B Amyes; David M Livermore
Journal:  Int J Antimicrob Agents       Date:  2006-03-24       Impact factor: 5.283

5.  Bloodstream infection due to Acinetobacter spp: epidemiology, risk factors and impact of multi-drug resistance.

Authors:  D W Wareham; D C Bean; P Khanna; E M Hennessy; D Krahe; A Ely; M Millar
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-02-19       Impact factor: 3.267

6.  Structure-function studies of arginine at position 276 in CTX-M beta-lactamases.

Authors:  Francisco José Pérez-Llarena; Mónica Cartelle; Susana Mallo; Alejandro Beceiro; Astrid Pérez; Rosa Villanueva; Antonio Romero; Richard Bonnet; Germán Bou
Journal:  J Antimicrob Chemother       Date:  2008-02-14       Impact factor: 5.790

Review 7.  An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii.

Authors:  Lenie Dijkshoorn; Alexandr Nemec; Harald Seifert
Journal:  Nat Rev Microbiol       Date:  2007-12       Impact factor: 60.633

8.  A PCR-based method to differentiate between Acinetobacter baumannii and Acinetobacter genomic species 13TU.

Authors:  P G Higgins; H Wisplinghoff; O Krut; H Seifert
Journal:  Clin Microbiol Infect       Date:  2007-09-10       Impact factor: 8.067

9.  Use of sequence-based typing and multiplex PCR to identify clonal lineages of outbreak strains of Acinetobacter baumannii.

Authors:  J F Turton; S N Gabriel; C Valderrey; M E Kaufmann; T L Pitt
Journal:  Clin Microbiol Infect       Date:  2007-08       Impact factor: 8.067

10.  Acinetobacter radioresistens as a silent source of carbapenem resistance for Acinetobacter spp.

Authors:  Laurent Poirel; Samy Figueiredo; Vincent Cattoir; Alessandra Carattoli; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2008-01-14       Impact factor: 5.191

View more
  79 in total

1.  First Description of Two Sequence Type 2 Acinetobacter baumannii Isolates Carrying OXA-23 Carbapenemase in Pagellus acarne Fished from the Mediterranean Sea near Bejaia, Algeria.

Authors:  Soumia Brahmi; Abdelaziz Touati; Axelle Cadière; Nassima Djahmi; Alix Pantel; Albert Sotto; Jean-Philippe Lavigne; Catherine Dunyach-Remy
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

2.  A Multicenter Study in Mexico Finds Acinetobacter baumannii Clinical Isolates Belonging to Clonal Complexes 636B (113B) and 92B Harboring OXA-72, OXA-239, and OXA-469.

Authors:  Ana M Gonzalez-Villoria; Elsa Tamayo-Legorreta; Ulises Garza-Ramos; Humberto Barrios; Alejandro Sanchez-Pérez; Nadia Rodríguez-Medina; Naville Uribe-Aviña; Miguel A Cevallos; Jesus Silva-Sanchez
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

3.  Genotyping and molecular characterization of clinical Acinetobacter baumannii isolates from a single hospital in Southwestern Iran.

Authors:  Ahmad Farajzadeh Sheikh; Mohammad Savari; Effat Abbasi Montazeri; Saeed Khoshnood
Journal:  Pathog Glob Health       Date:  2020-06-19       Impact factor: 2.894

4.  First Occurrence of OXA-72-Producing Acinetobacter baumannii in Serbia.

Authors:  Laurent Dortet; Rémy A Bonnin; Sandrine Bernabeu; Lélia Escaut; Daniel Vittecoq; Delphine Girlich; Dilek Imanci; Nicolas Fortineau; Thierry Naas
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

Review 5.  Acinetobacter baumannii: evolution of antimicrobial resistance-treatment options.

Authors:  Yohei Doi; Gerald L Murray; Anton Y Peleg
Journal:  Semin Respir Crit Care Med       Date:  2015-02-02       Impact factor: 3.119

6.  Structural Basis for Enhancement of Carbapenemase Activity in the OXA-51 Family of Class D β-Lactamases.

Authors:  Clyde A Smith; Nuno Tiago Antunes; Nichole K Stewart; Hilary Frase; Marta Toth; Katherine A Kantardjieff; Sergei Vakulenko
Journal:  ACS Chem Biol       Date:  2015-06-12       Impact factor: 5.100

7.  High frequency of Acinetobacter soli among Acinetobacter isolates causing bacteremia at a tertiary hospital in Japan.

Authors:  Shiro Endo; Hisakazu Yano; Hajime Kanamori; Shinya Inomata; Tetsuji Aoyagi; Masumitsu Hatta; Yoshiaki Gu; Koichi Tokuda; Miho Kitagawa; Mitsuo Kaku
Journal:  J Clin Microbiol       Date:  2014-01-08       Impact factor: 5.948

8.  Characterization of blaOXA-143 variants in Acinetobacter baumannii and Acinetobacter pittii.

Authors:  Esther Zander; Rémy A Bonnin; Harald Seifert; Paul G Higgins
Journal:  Antimicrob Agents Chemother       Date:  2014-02-24       Impact factor: 5.191

Review 9.  Treatment options for carbapenem-resistant and extensively drug-resistant Acinetobacter baumannii infections.

Authors:  J Alexander Viehman; M Hong Nguyen; Yohei Doi
Journal:  Drugs       Date:  2014-08       Impact factor: 9.546

10.  Dissemination of 16S rRNA methylase ArmA-producing acinetobacter baumannii and emergence of OXA-72 carbapenemase coproducers in Japan.

Authors:  Tatsuya Tada; Tohru Miyoshi-Akiyama; Kayo Shimada; Masahiro Shimojima; Teruo Kirikae
Journal:  Antimicrob Agents Chemother       Date:  2014-02-18       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.